The 2010 WHO ART guidelines which recommends initiation of ART for all PLHIV with CD4 count of ≤350/mm3 is a welcome change in this regard which may not only prevent TB cases from occurring but may also ensure that those who develop TB would have higher CD4 counts and consequently the likelihood of better clinical outcomes. Here, CD4 is linked to tuberculosis.